Stimuli-responsive, smart, or intelligent polymers are materials that significantly change their physical or chemical properties when there is a small change in the surrounding environment due to either internal or external stimuli. In the last two decades or so, there has been tremendous growth in the strategies to develop various types of stimuli-responsive polymer (SRP) materials/systems that are suitable for various fields, including biomedical, material science, nanotechnology, biotechnology, surface and colloid sciences, biochemistry, and the environmental field. The wide acceptability of SRPs is due to their availability in different architectural forms such as scaffolds, aggregates, hydrogels, pickering emulsions, core-shell particles, nanogels, micelles, membranes, capsules, and layer-by-layer films. The present review focuses on different types of SRPs, such as physical, chemical, and biological, and various important applications, including controlled drug delivery (CDD), stabilization of colloidal dispersion, diagnostics (sensors and imaging), tissue engineering, regenerative medicines, and actuators. The applications of SRPs have immense potential in various fields, and the author hopes these polymers will add a new field of applications through new concepts.

Multiple myeloma (MM) is a hematologic cancer characterized by clonal proliferation of plasma cells within the bone marrow. It is the most serious form of plasma cell dyscrasias, whose complications—hypercalcemia, renal failure, anemia, and lytic bone lesions—are severe and justify the therapeutic management. Imaging of bone lesions is a cardinal element in the diagnosis, staging, study of response to therapy, and prognostic evaluation of patients with MM. Historically, the skeletal radiographic workup (SRW), covering the entire axial skeleton, has been used to detect bone lesions. Over time, new imaging techniques that are more powerful than SRW have been evaluated. Low-dose and whole-body computed tomography (CT) supplants SRW for the detection of bone involvement, but is of limited value in assessing therapeutic response. Bone marrow MRI, initially studying the axial pelvic-spinal skeleton and more recently the whole body, is an attractive alternative. Beyond its non-irradiating character, its sensitivity for the detection of marrow damage, its capacity to evaluate the therapeutic response and its prognostic value has been demonstrated. This well-established technique has been incorporated into disease staging systems by many health systems and scientific authorities. Along with positron emission tomography (PET)-18 fluorodeoxyglucose CT, it constitutes the current imaging of choice for MM. This article illustrates the progress of the MRI technique over the past three decades and situates its role in the management of patients with MM.

An α, α^′-dipyridyl adduct of a complex compound hexaaquatribenzene-1,2,4,5-tetracarbonatotetra iron (III) with porous structure was synthesized for the first time. According to the results of elemental, X-ray, IR-spectroscopic and differential-thermal analyses the individuality, chemical formula, thermal destruction, and form of coordination of acidic anion and dipyridyl were established. During interaction of a complex compound with dipyridyl, it completely loses all crystallization molecule of water resulting in a compound with a chemical formula of Fe₄(C₆H₂(COO)₄)₃(dpy)₂(dipyridyl). Using the identification of diffraction pattern the parameters of lattice cell of the complex compound were determined.